Laboratory Forecast, price target & analysts
Laboratory Target price 2025 - Analyst rating & recommendation
Laboratory Classifications & Recommendation:
Laboratory Price Target
| Target Price | $272.29 |
| Price | $217.12 |
| Potential |
25.41%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Laboratory 2026 .
The average Laboratory target price is $272.29.
This is
25.41%
register free of charge
$300.00
38.17%
register free of charge
$240.00
10.54%
register free of charge
|
|
| A rating was issued by 23 analysts: 18 Analysts recommend Laboratory to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratory stock has an average upside potential 2026 of
25.41%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 13.01 | 13.92 |
| 6.97% | 6.97% | |
| EBITDA Margin | 15.67% | 17.19% |
| 11.77% | 9.73% | |
| Net Margin | 5.67% | 7.53% |
| 73.25% | 32.87% |
16 Analysts have issued a sales forecast Laboratory 2025 . The average Laboratory sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Laboratory EBITDA forecast 2025. The average Laboratory EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Laboratory Analysts have issued a net profit forecast 2025. The average Laboratory net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 8.84 | 12.56 |
| 85.32% | 42.08% | |
| P/E | 17.56 | |
| EV/Sales | 1.74 |
7 Analysts have issued a Laboratory forecast for earnings per share. The average Laboratory EPS is
This results in the following potential growth metrics and future valuations:
Current Laboratory Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
| Redburn Atlantic |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 10 2025 |
|
Locked
Redburn Atlantic:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 07 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Feb 06 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
